K. Christopher Garcia, Ph.D.

Affiliations: 
Molecular & Cellular Physiology Stanford University, Palo Alto, CA 
Website:
http://med.stanford.edu/garcialab.html
Google:
"Christopher Garcia"
Bio:

https://profiles.stanford.edu/chris-garcia
https://scholar.google.com/citations?user=2d7fZrIAAAAJ&hl=en

Mean distance: 9.36
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Horton BL, D'Souza AD, Zagorulya M, et al. (2023) Overcoming lung cancer immunotherapy resistance by combining non-toxic variants of IL-12 and IL-2. Jci Insight
Tsutsumi N, Masoumi Z, James SC, et al. (2023) Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesis. Cell
Caveney NA, Tsutsumi N, Garcia KC. (2023) Structural insight into guanylyl cyclase receptor hijacking of the kinase-Hsp90 regulatory mechanism. Elife. 12
Abhiraman GC, Bruun TUJ, Caveney NA, et al. (2023) A structural blueprint for interleukin-21 signal modulation. Cell Reports. 42: 112657
Yang H, Ulge UY, Quijano-Rubio A, et al. (2023) Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffolds. Nature Chemical Biology
Saxton RA, Caveney NA, Moya-Garzon MD, et al. (2023) Structural insights into the mechanism of leptin receptor activation. Nature Communications. 14: 1797
Tsutsumi N, Hwang S, Waghray D, et al. (2023) Structure of the Wnt-Frizzled-LRP6 initiation complex reveals the basis for coreceptor discrimination. Proceedings of the National Academy of Sciences of the United States of America. 120: e2218238120
Caveney NA, Saxton RA, Waghray D, et al. (2023) Structural basis of Janus kinase trans-activation. Cell Reports. 42: 112201
Caveney NA, Tsutsumi N, Garcia KC. (2023) Structural insight into guanylyl cyclase receptor hijacking of the kinase-Hsp90 regulatory mechanism. Biorxiv : the Preprint Server For Biology
Stern LA, Gholamin S, Moraga I, et al. (2022) Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy. Proceedings of the National Academy of Sciences of the United States of America. 119: e2112006119
See more...